Omnio has raised an oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based therapy for hard-to-heal chronic wounds.

Provenance

Sources

1. EU-Startups · 02 Oct 2026

   Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds

   Omnio, a Umeå-based BioTech startup, has raised an oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based therapy for hard-to-heal chronic wounds…